SitesBLAST
Comparing 7025630 FitnessBrowser__ANA3:7025630 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
2v27B Structure of the cold active phenylalanine hydroxylase from colwellia psychrerythraea 34h (see paper)
62% identity, 96% coverage: 11:271/271 of query aligns to 4:264/272 of 2v27B
4etlA Crystallographic structure of phenylalanine hydroxylase from chromobacterium violaceum f258a mutation (see paper)
48% identity, 80% coverage: 23:238/271 of query aligns to 29:244/277 of 4etlA
3tcyA Crystallographic structure of phenylalanine hydroxylase from chromobacterium violaceum (cpah) bound to phenylalanine in a site distal to the active site (see paper)
48% identity, 80% coverage: 23:238/271 of query aligns to 29:244/277 of 3tcyA
- active site: H132 (= H126), H137 (= H131), E178 (= E171), S197 (= S191)
- binding cobalt (ii) ion: H132 (= H126), H137 (= H131), E178 (= E171)
- binding phenylalanine: A152 (≠ I146), Y153 (= Y147), G156 (≠ L150), K159 (≠ N153), L169 (= L162), L172 (= L165)
Sites not aligning to the query:
1ltvA Crystal structure of chromobacterium violaceum phenylalanine hydroxylase, structure with bound oxidized fe(iii) (see paper)
48% identity, 80% coverage: 23:238/271 of query aligns to 27:242/275 of 1ltvA
1ltzA Crystal structure of chromobacterium violaceum phenylalanine hydroxylase, structure has bound iron (iii) and oxidized cofactor 7, 8-dihydrobiopterin (see paper)
48% identity, 80% coverage: 23:238/271 of query aligns to 29:244/274 of 1ltzA
- active site: H132 (= H126), H137 (= H131), E178 (= E171), S197 (= S191)
- binding fe (iii) ion: H132 (= H126), H137 (= H131), E178 (= E171)
- binding 7,8-dihydrobiopterin: G94 (≠ A88), L95 (= L89), I96 (= I90), D98 (≠ F92), F101 (= F95), A170 (= A163), Y173 (= Y166)
P90986 Tyrosine 3-monooxygenase; Abnormal catecholamine distribution protein 2; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Caenorhabditis elegans (see 4 papers)
36% identity, 85% coverage: 16:244/271 of query aligns to 233:461/519 of P90986
Sites not aligning to the query:
- 35 modified: Phosphoserine; by PKA
- 276:519 mutation Missing: In e1112; spontaneously induces activation of the crh-1/CREB1 transcription factor in cholinergic SIA neurons in the absence and presence of food. Reduces swimming-induced paralysis in response to amphetamine. Defective male mating behavior.
5jk8A Phenylalanine hydroxylase from dictyostelium - bh2, norleucine complex
38% identity, 85% coverage: 3:233/271 of query aligns to 124:355/390 of 5jk8A
- active site: H250 (= H126), H255 (= H131), E295 (= E171), S314 (= S191)
- binding fe (iii) ion: H250 (= H126), H255 (= H131), E295 (= E171)
- binding 7,8-dihydrobiopterin: G212 (≠ A88), L213 (= L89), L214 (≠ I90), A216 (≠ F92), F219 (= F95), S287 (≠ A163), Y290 (= Y166)
- binding norleucine: R235 (= R111), Y242 (= Y118), T243 (≠ L119), H250 (= H126), E295 (= E171), G311 (= G188), S314 (= S191), S315 (= S192)
- binding piperazine-n,n'-bis(2-ethanesulfonic acid): C202 (≠ T78), T203 (= T79), R226 (≠ K102), P262 (= P138), D266 (≠ H142)
Sites not aligning to the query:
5jk5A Phenylalanine hydroxylase from dictyostelium - bh2 complex
38% identity, 85% coverage: 3:233/271 of query aligns to 133:364/400 of 5jk5A
- active site: H259 (= H126), H264 (= H131), E304 (= E171), S323 (= S191)
- binding fe (iii) ion: H259 (= H126), H264 (= H131), E304 (= E171)
- binding 7,8-dihydrobiopterin: V219 (= V86), G221 (≠ A88), L222 (= L89), L223 (≠ I90), S224 (= S91), A225 (≠ F92), F228 (= F95), L229 (≠ F96), S296 (≠ A163), Y299 (= Y166)
- binding piperazine-n,n'-bis(2-ethanesulfonic acid): T212 (= T79), R235 (≠ K102), P271 (= P138), D275 (≠ H142)
Sites not aligning to the query:
P04177 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Rattus norvegicus (Rat) (see 7 papers)
35% identity, 91% coverage: 21:267/271 of query aligns to 222:464/498 of P04177
- Q310 (≠ P105) mutation to H: Does not affect Vmax for phenylalanine. Increases KM for phenylalanine.
- H323 (≠ Y118) mutation to Y: Does not affect Vmax for phenylalaninet. Increases KM for phenylalanine.
- H331 (= H126) binding
- H336 (= H131) binding
- W372 (= W167) mutation to F: Does not affect substrate specificity.
- E376 (= E171) binding
- D425 (≠ I222) Important for substrate specificity; mutation to V: Shifts substrate specificity from tyrosine to phenylalanine.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 19 modified: Phosphoserine; by CaMK2
- 31 modified: Phosphoserine
- 40 modified: Phosphoserine; by CaMK2 and PKA
P17289 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Bos taurus (Bovine) (see 2 papers)
34% identity, 94% coverage: 14:267/271 of query aligns to 208:457/491 of P17289
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 19 modified: Phosphoserine; by CaMK2
- 31 modified: Phosphoserine
- 40 modified: Phosphoserine; by CaMK2 and PKA
2tohA Tyrosine hydroxylase catalytic and tetramerization domains from rat (see paper)
35% identity, 91% coverage: 21:267/271 of query aligns to 60:302/336 of 2tohA
- active site: H169 (= H126), H174 (= H131), E214 (= E171), S233 (= S191)
- binding fe (iii) ion: H169 (= H126), H174 (= H131), E214 (= E171)
- binding 7,8-dihydrobiopterin: V129 (= V86), L132 (= L89), L133 (≠ I90), Y138 (≠ F95), Q148 (≠ P105), T150 (≠ A107), P165 (= P122), E170 (= E127), S206 (≠ A163), Y209 (= Y166), E214 (= E171)
2xsnA Crystal structure of human tyrosine hydroxylase catalytic domain
35% identity, 94% coverage: 14:267/271 of query aligns to 53:302/335 of 2xsnA
6zvpD Atomic model of the em-based structure of the full-length tyrosine hydroxylase in complex with dopamine (residues 40-497) in which the regulatory domain (residues 40-165) has been included only with the backbone atoms (see paper)
35% identity, 94% coverage: 14:267/271 of query aligns to 175:424/458 of 6zvpD
Sites not aligning to the query:
6zn2A Partial structure of tyrosine hydroxylase in complex with dopamine showing the catalytic domain and an alpha-helix from the regulatory domain involved in dopamine binding. (see paper)
35% identity, 94% coverage: 14:267/271 of query aligns to 52:301/335 of 6zn2A
- binding fe (iii) ion: H168 (= H126), H173 (= H131), E213 (= E171)
- binding l-dopamine: L132 (≠ I90), P164 (= P122), H168 (= H126), H173 (= H131), Y208 (= Y166), E213 (= E171)
- binding : L132 (≠ I90), S133 (= S91), A134 (≠ F92), D198 (≠ K156), E199 (= E157), I201 (≠ R159), E202 (≠ V160), S205 (≠ A163), T206 (≠ R164), Y208 (= Y166), W209 (= W167), Y260 (= Y220), D262 (≠ I222)
P07101 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Homo sapiens (Human) (see 32 papers)
35% identity, 94% coverage: 14:267/271 of query aligns to 245:494/528 of P07101
- H246 (≠ S15) to Y: in ARSEGS; loss of about 40% of tyrosine 3-monooxygenase activity
- G247 (≠ A16) to S: in ARSEGS; loss of about 50% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs762304556
- E259 (= E28) to G: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T276 (≠ G45) to P: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs28934581
- P301 (= P66) to A: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- F309 (≠ V74) to S: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T314 (= T79) to M: in ARSEGS; parkinsonian symptoms in infancy; loss of about 80% of tyrosine 3-monooxygenase activity; dbSNP:rs121917764
- R319 (≠ A84) to P: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- R328 (≠ G93) to W: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs1428589694
- R337 (≠ K102) to H: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs28934580
- C359 (≠ I124) to F: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs121917765
- F375 (= F140) to L: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs763198914
- A376 (= A141) to V: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- L387 (= L152) to M: in ARSEGS; no effect on tyrosine 3-monooxygenase activity
- I394 (≠ R159) to T: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T399 (≠ R164) to M: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs1057520384
- Q412 (= Q178) to K: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; reduced affinity for L-tyrosine; dbSNP:rs121917762
- G414 (= G180) to R: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs370962049
- G428 (= G194) to R: in ARSEGS; phenotype with prominent levodopa-responsive myoconus-dystonia (M-D); dbSNP:rs1264884607
- R441 (≠ K208) to P: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs367874223
- S467 (≠ H234) to G: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- P492 (= P265) to L: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs767635052
- T494 (= T267) to M: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs45471299
Sites not aligning to the query:
- 19 modified: Phosphoserine; by CaMK2; S → C: found in a patient with ARSEGS; unknown pathological significance; dbSNP:rs766704202
- 62 modified: Phosphoserine; S→A: Affects subcellular localization. Accumulates mainly in the soma of the neuroblastoma cells.; S→E: Does not affect subcellular localization. Distributed throughout the soma and neurites.
- 71 modified: Phosphoserine; by CaMK2 and PKA; S→E: Suppresses feedback inhibition induced by dopamine. Suppresses feedback inhibition induced by dopamine; when associated with A-207.
- 112 V → M: in dbSNP:rs6356
- 207 C → Y: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; C→A: Suppresses the decrease in tyrosine 3-monooxygenase activity induced by NEM modification. Suppresses feedback inhibition induced by dopamine; when associated with E-71.
- 227 D → G: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- 233 R → H: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs80338892
- 236 L → P: in ARSEGS; severe parkinsonian symptoms in early infancy; strongly reduced stability and tyrosine 3-monooxygenase activity; rare mutation; dbSNP:rs121917763
- 241 A → T: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs1260455415
- 498 D → G: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs771351747
- 499 V → M: in dbSNP:rs1800033
- 510 L → Q: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
P17752 Tryptophan 5-hydroxylase 1; Tryptophan 5-monooxygenase 1; EC 1.14.16.4 from Homo sapiens (Human) (see paper)
35% identity, 91% coverage: 22:268/271 of query aligns to 164:406/444 of P17752
- H272 (= H126) binding
- H277 (= H131) binding
- E317 (= E171) binding
3e2tA The catalytic domain of chicken tryptophan hydroxylase 1 with bound tryptophan (see paper)
37% identity, 91% coverage: 22:268/271 of query aligns to 61:303/307 of 3e2tA